arrow
M

Martin Pulé

university college london
H指数:54
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis

CAR T细胞疗法选择性清除异种移植和人类类器官模型中骨髓纤维化的疾病驱动突变钙网蛋白细胞

2026-01-010
OA
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies

调节性T细胞耗竭促进髓系细胞活化及胶质母细胞瘤对anti-PD1和肿瘤靶向抗体的反应

Immunity
IF26.3
2025-05-290
OA
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia

抗CD21嵌合抗原受体T细胞治疗T细胞急性淋巴细胞白血病的临床前开发

2025-04-160
PRE
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia

成人b细胞急性淋巴细胞白血病的Obecabtagene自体白血病

2024-12-120
PRE
In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T-Cell Neoplasms
2024-12-100
PRE
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial
2024-11-110
OAAI
Risk Factors Associated with Sub-Optimal Outcomes Following Obecabtagene autoleucel (obe-cel) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): What We Have Learned from the FELIX Trial

与使用Obecabtagene autoleucel(obe-cel)治疗复发/难治性B细胞急性淋巴细胞白血病(R/R B-ALL)后效果不佳相关的风险因素:我们从FELIX试验中学到的经验

BLOOD
IF23.1
2024-11-050
PRE
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry

双T细胞常数 β 链 (TRBC)1和TRBC2染色通过流式细胞术鉴定T细胞肿瘤

2024-02-295
OAAI
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies

T细胞恶性肿瘤中靶向TRBC1和TRBC2的免疫疗法的结构指导工程

2024-02-215
OAAI
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
2024-02-010
OAAI
AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival

AKT抑制产生有效的多功能临床级AUTO1 car-t细胞,增强功能和生存

2023-09-1311
OAAI
Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia

与白血病儿童中持续存在的CD19 car-t细胞相关的转录特征

2023-07-0623
OAAI
Dual targeting of CD19 and CD22 against B-ALL a novel-sensitivity aCD22 CAR
2023-07-0117
OAAI
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

APRIL CAR在多发性骨髓瘤患者中的有限疗效表明使用天然配体进行CAR T细胞治疗的挑战

2023-06-3015
OAAI
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells

激活引发和细胞因子多功能性调节低亲和力CD19 CAR T细胞的增强功能

2023-04-2713
OAAI